Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (93) 93
life sciences & biomedicine (88) 88
neurosciences & neurology (68) 68
humans (66) 66
neurosciences (51) 51
clinical neurology (49) 49
male (48) 48
female (44) 44
adult (42) 42
middle aged (37) 37
multiple sclerosis (33) 33
biological and medical sciences (28) 28
neurology (28) 28
aged (25) 25
magnetic resonance imaging (20) 20
young adult (20) 20
medical sciences (19) 19
adolescent (16) 16
abridged index medicus (13) 13
animals (13) 13
neuromyelitis optica (13) 13
cerebrospinal fluid (12) 12
research (12) 12
aquaporin 4 - immunology (11) 11
fundamental and applied biological sciences. psychology (11) 11
central nervous system (10) 10
cohort studies (10) 10
diagnosis (10) 10
patients (10) 10
antibodies (9) 9
care and treatment (9) 9
multiple sclerosis and variants. guillain barré syndrome and other inflammatory polyneuropathies. leukoencephalitis (9) 9
aged, 80 and over (8) 8
analysis (8) 8
aquaporins (8) 8
biochemistry & molecular biology (8) 8
multiple sclerosis - genetics (8) 8
nuclear magnetic resonance--nmr (8) 8
rats (8) 8
vertebrates: nervous system and sense organs (8) 8
chemistry (7) 7
in situ hybridization (7) 7
multiple sclerosis - immunology (7) 7
neuroimaging (7) 7
physical sciences (7) 7
proteins (7) 7
brain - diagnostic imaging (6) 6
brain - pathology (6) 6
case-control studies (6) 6
chemistry, analytical (6) 6
disability evaluation (6) 6
immunoglobulin g (6) 6
immunology (6) 6
multiple sclerosis - pathology (6) 6
nervous system (6) 6
neuromyelitis optica - immunology (6) 6
psychiatry (6) 6
retrospective studies (6) 6
risk factors (6) 6
viral antibodies (6) 6
autoantibodies - blood (5) 5
autoradiography (5) 5
brain (5) 5
central neurotransmission. neuromudulation. pathways and receptors (5) 5
disease progression (5) 5
function and dysfunction of the nervous system (5) 5
genotype (5) 5
germany (5) 5
immunoglobulin g - blood (5) 5
ligands (5) 5
medicine & public health (5) 5
mice (5) 5
multiple sclerosis - drug therapy (5) 5
neuromyelitis optica - drug therapy (5) 5
polymorphism, single nucleotide - genetics (5) 5
positron emission tomography (5) 5
receptors, metabotropic glutamate - genetics (5) 5
usage (5) 5
age (4) 4
anesthesiology (4) 4
aquaporin 4 (4) 4
aquaporin-4 antibody (4) 4
atrophy (4) 4
autoantibodies - immunology (4) 4
autoimmune diseases (4) 4
autoimmunity (4) 4
biochemical research methods (4) 4
brain - metabolism (4) 4
cognitive ability (4) 4
csf (4) 4
inflammation (4) 4
interferon (4) 4
medizin (4) 4
multiple sclerosis - complications (4) 4
natalizumab (4) 4
nervous system diseases (4) 4
neurology. diseases of the nervous system (4) 4
pain (4) 4
positron-emission tomography - methods (4) 4
rats, wistar (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Eculizumab in the treatment of neuromyelitis optica spectrum disorder
by Giglhuber, Katrin and Berthele, Achim
Immunotherapy, ISSN 1750-743X, 10/2020, Volume 12, Issue 14, pp. 1053 - 1066
antibody therapeutics | autoimmunity | complement system | immunotherapy | neuromyelitis optica | Life Sciences & Biomedicine | Immunology | Science & Technology
Journal Article
Details down arrow
2. Full Text Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
by Trebst, Corinna and Trebst, Corinna and Jarius, Sven and Jarius, Sven and Berthele, Achim and Berthele, Achim and Paul, Friedemann and Paul, Friedemann and Schippling, Sven and Schippling, Sven and Wildemann, Brigitte and Wildemann, Brigitte and Borisow, Nadja and Borisow, Nadja and Kleiter, Ingo and Kleiter, Ingo and Aktas, Orhan and Aktas, Orhan and Kümpfel, Tania and Kümpfel, Tania and Neuromyelitis Opt Study Grp NEMOS and Neuromyelitis Optica Study Group (NEMOS)
Journal of neurology, ISSN 0340-5354, 1/2014, Volume 261, Issue 1, pp. 1 - 16
Neurology | Therapy | Neurosciences | Medicine & Public Health | Diagnostic tests | Neuromyelitis optica | Differential diagnosis | Neuroradiology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Medication Reconciliation - trends | Neuromyelitis Optica - therapy | Medication Reconciliation - standards | Diagnosis-Related Groups - standards | Humans | Neuromyelitis Optica - diagnosis | Care and treatment | Diagnosis | Index Medicus | Antibodies | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
by Schmidt, Paul and Gaser, Christian and Arsic, Milan and Buck, Dorothea and Förschler, Annette and Berthele, Achim and Hoshi, Muna and Ilg, Rüdiger and Schmid, Volker J and Zimmer, Claus and Hemmer, Bernhard and Mühlau, Mark
NeuroImage (Orlando, Fla.), ISSN 1053-8119, 02/2012, Volume 59, Issue 4, pp. 3774 - 3783
Multiple Sclerosis | FLAIR | Lesion segmentation | Voxel-based morphometry | Neuroimaging | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Neuroimaging - methods | Young Adult | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Multiple Sclerosis - pathology | Adult | Multiple sclerosis | Algorithms | Automation | Nuclear magnetic resonance--NMR | Maps | Bias | Software | Clinical medicine | Growth models | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
by Kowarik, Markus C and Cepok, Sabine and Sellner, Johann and Grummel, Verena and Weber, Martin S and Korn, Thomas and Berthele, Achim and Hemmer, Bernhard
Journal of neuroinflammation, ISSN 1742-2094, 05/2012, Volume 9, Issue 1, pp. 93 - 93
B cells and plasmablasts | BAFF | CXCL12 | CCL21 | CCL19 | CXCL13 | APRIL | Neurosciences | Immunology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | B-Lymphocyte Subsets - physiology | B-Lymphocyte Subsets - pathology | Humans | Middle Aged | Male | Nervous System Diseases - diagnosis | Cell Movement - physiology | Young Adult | Inflammation Mediators - cerebrospinal fluid | B-Lymphocyte Subsets - metabolism | Chemokine CXCL13 - biosynthesis | Adolescent | Inflammation Mediators - metabolism | Nervous System Diseases - cerebrospinal fluid | Adult | Female | Aged | Chemokine CXCL13 - cerebrospinal fluid | Cohort Studies | Nervous System Diseases - pathology | Nervous system diseases | Multiple sclerosis | Immune response | Cytokines | Immunoglobulin G | Albumin | Central nervous system diseases | B cells | Immunoglobulin A | Enzyme-linked immunosorbent assay | Chemokines | Flow cytometry | Disease | Manuscripts | Recruitment | Proteins | Studies | Lymphocytes | Herpes viruses | Ligands | Immune system | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
by Pittock, Sean J and Berthele, Achim and Fujihara, Kazuo and Kim, Ho Jin and Levy, Michael and Palace, Jacqueline and Nakashima, Ichiro and Terzi, Murat and Totolyan, Natalia and Viswanathan, Shanthi and Wang, Kai-Chen and Pace, Amy and Fujita, Kenji P and Armstrong, Róisín and Wingerchuk, Dean M
The New England journal of medicine, ISSN 0028-4793, 08/2019, Volume 381, Issue 7, pp. 614 - 625
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Disability Evaluation | Antibodies, Monoclonal, Humanized - adverse effects | Neuromyelitis Optica - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Aquaporin 4 - immunology | Double-Blind Method | Immunoglobulin G - blood | Autoantibodies - blood | Humans | Immunosuppressive Agents - therapeutic use | Male | Secondary Prevention | Neuromyelitis Optica - immunology | Disease Progression | Complement Inactivating Agents - therapeutic use | Quality of Life | Adult | Female | Immunosuppressive Agents - adverse effects | Respiratory Tract Infections - etiology | Complement Inactivating Agents - adverse effects | Drug Therapy, Combination | Complement C5 - antagonists & inhibitors | Headache - chemically induced | Control | Neuromyelitis optica | Drug therapy | Risk factors | Aquaporin 4 | Headache | Spinal cord | Immunoglobulins | Intravenous administration | Complement inhibitors | Physicians | Aquaporins | Immunoglobulin G | Central nervous system | Nervous system | Infections | Complement | Patients | Immunosuppressive agents | Regulatory approval | Design | Neuromyelitis | Medical laboratories | Empyema | Respiratory tract diseases | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Selenium speciation in paired serum and cerebrospinal fluid samples
by Solovyev, Nikolay and Solovyev, Nikolay and Berthele, Achim and Berthele, Achim and Michalke, Bernhard and Michalke, Bernhard
Analytical and bioanalytical chemistry, ISSN 1618-2642, 2/2013, Volume 405, Issue 6, pp. 1875 - 1884
Biochemistry, general | Glutathione peroxidase | Chemistry | Analytical Chemistry | Food Science | Characterization and Evaluation of Materials | Serum | Laboratory Medicine | Cerebrospinal fluid | Selenium speciation | Thioredoxin reductase | Environmental Monitoring/Analysis | Biochemistry & Molecular Biology | Physical Sciences | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology | Organoselenium Compounds - blood | Limit of Detection | Selenoprotein P - blood | Glutathione Peroxidase - blood | Humans | Reference Values | Organoselenium Compounds - cerebrospinal fluid | Serum Albumin - analysis | Selenomethionine - cerebrospinal fluid | Selenomethionine - blood | Selenoprotein P - cerebrospinal fluid | Glutathione Peroxidase - cerebrospinal fluid | Thioredoxin-Disulfide Reductase - blood | Thioredoxin-Disulfide Reductase - cerebrospinal fluid | Quality Control | Composition | Chemical properties | Research | Chemical species | Index Medicus | Correlation | Mathematical analysis | Serum albumin | Deviation | Serums | Speciation | Standards
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
by Srivastava, Rajneesh and Aslam, Muhammad and Kalluri, Sudhakar Reddy and Schirmer, Lucas and Buck, Dorothea and Tackenberg, Björn and Rothhammer, Veit and Chan, Andrew and Gold, Ralf and Berthele, Achim and Bennett, Jeffrey L and Korn, Thomas and Hemmer, Bernhard
The New England journal of medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 2, pp. 115 - 123
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Organic mental disorders. Neuropsychology | General aspects | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Epitope Mapping | Potassium Channels, Inwardly Rectifying - adverse effects | Immunoglobulin G - blood | Autoantibodies - blood | Humans | Multiple Sclerosis - genetics | Case-Control Studies | Autoantibodies - immunology | Animals | Potassium Channels, Inwardly Rectifying - immunology | Proteomics | Multiple Sclerosis - immunology | Neuroglia - metabolism | Mice | Brain - immunology | Potassium Channels, Inwardly Rectifying - metabolism | Multiple Sclerosis - metabolism | Multiple sclerosis | Care and treatment | Immune response | Drug targeting | Regulation | Research | Potassium channels | Health aspects | Cerebellum | Nuclear magnetic resonance--NMR | Autoantibodies | Disease | Potassium channels (inwardly-rectifying) | Astrocytes | Immunoglobulin G | Glial fibrillary acidic protein | Central nervous system | Glial cells | Membrane proteins | Serum levels | Neurological diseases | Pathogenicity | Proteins | Complement activation | Demyelination | Autoimmune diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text CD20 monoclonal antibodies for the treatment of multiple sclerosis: up-to-date
by Ancau, Mihai and Berthele, Achim and Hemmer, Bernhard
Expert opinion on biological therapy, ISSN 1471-2598, 08/2019, Volume 19, Issue 8, pp. 829 - 843
ublituximab | CD20 monoclonal antibody | ocrelizumab | B-cell therapy | ofatumumab | multiple sclerosis | rituximab | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Antigens, CD20 - immunology | B-Lymphocytes - drug effects | B-Lymphocytes - immunology | Antibodies, Monoclonal - administration & dosage | Humans | Multiple Sclerosis - immunology | Multiple Sclerosis - drug therapy | Randomized Controlled Trials as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights